Alopecia News

Beneath the Surface is a video series in which Joel M. Gelfand, MD, MSCE, Healio Dermatology Chief Medical Editor, discusses hot topics in the field with leading experts.

The NIH has awarded Emma Guttman-Yassky, MD, PhD, a $6.6 million grant to investigate dupilumab as a treatment for children with alopecia areata, Mount Sinai announced in a press release.

Beneath the Surface is a video series in which Joel M. Gelfand, MD, MSCE, Healio Dermatology Chief Medical Editor, discusses hot topics in the field with leading experts.

Healio has compiled April’s most-read news in dermatology.

Ritlecitinib was well tolerated and safe when continually used to treat alopecia areata in patients aged 12 years and older, according to a study.

In this Healio exclusive video, Ronda S. Farah, MD, FAAD, talks about a session at this year’s American Academy of Dermatology Annual Meeting on addressing misinformation on social media and tips for dermatologists.

Low-dose oral minoxidil was similarly efficacious as the drug’s topical version in male androgenetic alopecia, according to a study.

Healio has compiled March’s most-read news in dermatology.

Ectodermal dysplasia, a condition associated with impaired quality of life, increased mortality and increased morbidity, may have a lower prevalence than previously reported, according to a study.

Prescribers have expressed an overall positive opinion toward the off-label use of low-dose oral minoxidil for the treatment of androgenetic alopecia, though opinions varied based on years of experience, according to a study.